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ABSTRACT 
BACKGROUND AND OBJECTIVES :  
Dysfunctional uterine bleeding is an abnormal bleeding from the  
uterus in absence of organic disease of genital tract and demonstratable 
extra-genital  cause. Thyroid dysfunction is marked by large number of 
menstrual aberrations. 
This study aimed at detecting thyroid dysfunction  and  thyroid  
related  complaints in patients with a provisional diagnosis  of DUB refer 
positive cases to physician for further evaluation. 
METHODS:  
100 cases of clinically diagnosed DUB were taken from obstetrics 
and gynaecology department Coimbatore medical college hospital 
Coimbatore tamilnadu. 
    All patients from puberty tovpremenopausal age groups 
presenting as menorrhagia, acyclical metropathia, polymenorrhagia, 
metrorrhagia, oligomenorrhea, polymenorrhea and hypomenorrhea were 
tested for their thyroid function by T3, T4, TSH estimations in their 
serum. Patients on hormonal treatment, IUCD users, or had bleeding 
disorders were excluded from the study. 
RESULTS :  
23% of patients who were studied had thyroid dysfunction of 
which 13%of patients had subclinical hypothyroidism, 7% of patients had 
hypothyroidism and only 3% of patients had hyperthyroidism. The 
commonest bleeding abnormality in subclinical hypothyroid patients 
were polymenorrhoea and menorrhagia. All hyperthyroid cases were 
oligomenorrhoeic. most common symptoms of hypothyroidism are 
fatigue followed by increased weight gain ,dry skin, cold intolerance. 
INTERPRETATION AND CONCLUSION  
Both subclinical hypothyroid and profoundly hypothyroid cases  
together were the commonest thyroid dysfunction and menorrhagia was 
their commonest menstrual abnormality. So this study concludes that 
biochemical evaluation of thyroid functioning should be made mandatory 
in all provisionally diagnosed cases of DUBto detect thyroid dysfunction. 
Thyroid  function tests  should also  be done in  patients  presenting  with  
fatigue, weight gain ,lethargy  in addition  to  infertility, delayed  puberty 
and recurrent  abortions. 
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INTRODUCTION 
 
Dysfunctional uterine bleeding is an abnormal bleeding from the 
uterus in the absence of organic disease of genital tract and demonstrable 
extra genital cause.
1
 DUB accounts for 10% of the gynecology related 
complaints. Thyroid dysfunction is also marked by large number of 
menstrual aberrations. 
            Dysfunctional uterine bleeding (DUB) affects about 5% of 
menstruating women, yet the majority of medical practitioners who 
manage the problem do not adequately understand the underlying  
pathophysiology  nor the principles involved in appropriate management. 
Both hypo as well as hyperthyroidism are associated with a variety 
of changes in reproductive function including delayed onset of puberty, 
anovulatory cycles and abnormally high foetal wastage.
2
 Clinical 
experiences show increased menstrual flow to be the most common 
reproductive system manifestation of hypothyroidism. 
           Reproductive failure and lactation failure also preceded thyroid 
dysfunction or goitre. Reproductive dysfunction may therefore be 
considered as one of the presenting symptoms of thyroid disorders in 
women, keeping in mind both menstrual irregularities and lactation 
  
 
 
 
failure may also arise from other common or idiopathic origins. 
Especially in women with menstrual irregularities in the perimenopausal  
age if thyroid dysfunction is detected, pharmacotherapy may be a 
superior alternative to surgical interventions like hysterectomy.  
      Although the occurrence of menstrual disturbances in hypothyroid 
woman has been documented, the number of hypothyroid patients  
originally requiring treatment for menorrhagia has not been carefully 
elicitated
3
 Moreover majority of the cases has subclinical hypothyroidism 
and easily pass unrecognized. Danese MD et al. recommend 
hypothyroidism is frequent enough to warrant consideration in most older 
woman, justifying screening even in asymptomatic older women.
4 
The introduction of serum thyroxine (T4) and serum thyroid 
stimulating hormone (TSH) radioimmunoassay has increased the 
sensitivity and specificity of thyroid function testing. The serum TSH 
assay has been shown to be a sensitive indicator of diminished thyroid 
functional reserve, since TSH levels become elevated before circulating 
serum thyroxine levels fall below the normal range.
5 
 
  
 
 
 
Hence this study is to evaluate the thyroid function in patients 
having abnormal menstrual bleeding from puberty to premenopausal age 
groups which will be interesting and  justifiable  and will help in further 
management of DUB. 
  
  
 
 
 
AIMS & OBJECTIVES 
 
1) To study the thyroid related complaints in patients with 
dysfunctional uterine bleeding (reproductive age group) . 
2)  To evaluate thyroid function test abnormalities in patients with 
DUB. 
  
  
 
 
 
REVIEW OF LITERATURE 
 
‘The Thyroid Gland’ by  Rosalind Pitt Rivers and WR Trotter in 
1964 stated that the effect of thyroid deficiency on ovarian function that  
is a change in the rhythm of the oestrus cycle,  resulting in lengthening or 
irregularity. 'Chu' found that unruptured follicular count has increased 
and  the number of ovulations decreased in the ovaries of  the rabbits 
following thyroidectomy. He attributed these changes to an increase in 
the secretion of FSH and a decrease in that of LH by the pituitary.
6 
Gillmann and Gilbert has discussed the possibility of changes in 
the ovarian function observed in thyroid deficient primates and other 
animals are due to an alteration in the secretion of pituitary 
gonadotrophins.
6 
Scott and Mussey in 1964 reported that, incidence of subjective 
menorrhagia in myxoedema varied from 32 to 80% and menorrhagia may 
not infrequently be the presenting complaint. In contrast, hyperthyroidism  
was associated with oligomenorrhea and amenorrhea that are 
proportionate to severity of thyrotoxicosis. Menorrhagia associated with 
hypothyroidism responded quickly to thyroxine replacement, often in 
doses insufficient to correct the other manifestations of this 
  
 
 
 
condition,suggests that thyroxine in some way has direct effect on the 
spiral arterioles and on haemostasis during  menstruation.
7 
A study was done by measuring plasma levels of estrogen by 
radioimmunoassay for twenty eight consecutive days among 12 healthy 
euthyroid females and 15 thyrotoxic females- 10 with hypomenorrhea 
and 5 with amenorrhea.It showed that the menstrual abnormality which 
occurs in thyrotoxicosis was associated with increased circulating 
estrogen levels.
8 
Thyrotoxic women having amenorrhea has  a markedly increased  
plasma estrogen levels with a persistent  sharp peak of estrogen but 
without secondary rise seen with corpus luteum function. This suggests 
that failure of positive feedback effect of estrogen on hypothalamic 
pituitary axis with resultant failure of ovulation.
8
 The marked increase in  
estradiol  levels in thyrotoxicosis may be due to - 
i) Increased rate of conversion of testosterone and 
androstenedione to    estrogen. 
ii) Increased glandular secretion 
iii) Decreased metabolic rate 
 
  
 
 
 
           In  another study ,correlation of low platelet adhesiveness and 
Other hemostatic abnormalities, in Hypothyroidism was noted. This 
platelet dysfunction in combination with other factors can lead to 
menorrhagia in hypothyroidism.
9
 
Sheldon S. Stoffer, 1982 presented case reports on apparent 
relationship between menstrual irregularities and minimal thyroid 
insufficiency was documented by patients dramatic response to 
levothyroxine treatment. Two cases discontinued levothyroxine therapy  
and had menstrual abnormalities. The mechanism of menstrual 
dysfunction observed in patients with minimal thyroid insufficiency is 
not clear. 
Patients with long standing menstrual abnormalities  without 
obvious uterine pathology should be considered for thyroid function 
testing.
10 
Ivor M.D. Jackson, 1982 stated that thyrotropin releasing 
hormone was equally effective in stimulating prolactin secretion from the 
normal pituitary gland although the importance of this hypothalamic 
releasing factor in the regulation of the pituitary thyroid axis in human 
beings have to be studied further for understanding physiologic 
importance.
11   
"The incidence of hypothyroidism was shown to be as high 
  
 
 
 
as 44.44% in patients with menstrual disturbances. In this study 18 
patients of menstrual abnormalities are taken. Eight patients presenting 
with menorrhagia are in Group I and 5 cases had hypothyroidism. 
Hypothyroidism in these patients is due to low TSH levels so symptoms 
i.e., menorrhagia can be due to low levels of thyroid   hormone resulting 
in decreased metabolism of estrogen and hence relatively increased 
estrogen levels in blood  that  caused  menorrhagia. 
In a study involving 1110 oligomenorrheic patients, eight patients 
had hypothyroidism with raised TSH levels. So this was explained that in 
these eight hypothyroid patients thyroid gland was dysfunctional hence 
inspite of high TSH output,thyroid hormone production is low. Low 
thyroid hormone production provoked more TSH production. This 
elevated TSH levels cause increase in prolactin secretion which is 
responsible for oligomenorrhea. 
  
  
 
 
 
Group I : Menorrhagia patients with hypothyroidism 
Pituitary 
Low TSH production 
Normal thyroid gland 
Estrogen metabolism lowered 
Raised levels of Estrogen in circulation 
Menorrhagia 
A history of thyroid disorder in women with amenorrhea 
hyperprolactinemia syndrome was noted in a case control study. In 
females with hyper-prolactinemia and anovulation the underlying 
problem can be hypothyroidism and therefore thyroid function test should 
be done.
13 
 Seventy cases of puberty menorrhagia was studied, it was noted 
that five patients had hypothyroidism (7.15%) and 3 out of these 5 
hypothyroid patients had no other symptoms clinically suggestive of 
hypothyroidism. 
  
 
 
 
Hypothyroidism is the second common cause of excessive puberty 
bleeding. Adolescents with hypothyroidism tend to have mild symptoms 
than adult  patients.  
When 67 apparently euthyroid menorrhagic women were evaluated 
with a thyrotropin releasing hormone test, 15 (22%) out of 67 showed 
"mild primary hypothyroidism" characterized by an elevation of basal 
TSH level (5.9 MU/L), lowering of serum thyroxine levels (85nmol/l) 
and  exaggerated response of serum TSH and thyroxine to administration 
of thyrotrophin releasing hormone. The terms ‘early’ and ‘potential’ 
hypothyroidism describe  the  Preliminary Phase of hypothyroidism. 
During follow up, menorrhagia disappeared within 3 to 6 months and has 
not reappeared in 1 to 3 years in all patients with early hypothyroidism 
treated with L-thyroxine, also improvement in thyroid profile without  
change in  triiodothyronine  level  noted.
3 
Infrequent or absent ovulation is believed to result in relative 
estrogen excess (Goldsmith RE, et al 1952). Also these changes may be 
due to deficient production of luteinizing hormone .The fact that TSH 
level dropped significantly and the thyroxine levels rise significantly after 
L-thyroxine administration, with no change in the T3 level supports that 
  
 
 
 
menorrhagia may  be  an  another  example  that  is dependent on  
thyroxine and  not on  tri iodothyronine.
3 
This study further proposed that sensitive TSH assay might replace 
the thyrotropin releasing hormone test. It was also suggested that the 
terms 'early hypothyroidism 'to describe the condition in patients having 
symptoms and 'potential hypothyroidism' for those who are 
asymptomatic. 
Dysfunctional uterine bleeding (DUB), defined as abnormal 
uterine bleeding not caused by pelvic pathology, medications, systemic 
disease or pregnancy, is the most common cause of abnormal uterine 
bleeding but remains a diagnosis of exclusion. 
 A study was conducted on the hormonal profile of 
oligomenorrheic women. Radio immunoassay of TSH, LH and prolactin 
were done at intervals i.e., at 1
st
 day, 12
th
day and 20
th
 day of cycle and 
T3, T4, TSH were done randomly. This study has shown that prolactin 
and T3 play most significant role in deciding the FSH, LH levels and 
sometimes anovulation associated with amenorrhea. The cause of 
oligomenorrhea which is mostly associated with anovulation is related to 
either raised prolactin or T3 levels or due to hypothyroidism. 
Gonadotrophin levels are being  regulated  by  these  hormones.
1 
  
 
 
 
In a study it was showed that 33.3% patients with hypothyroidism 
had menorrhagia. The mechanism explained was "it seems that poor 
progesterone production is associated with persistent endometrial 
proliferation which may be responsible for massive bleeding.
2      
Another, 
mechanism  for  this  may  be  failure of LH secretion. 44.4% patients 
with hypothyroidism had  oligomenorrhea. This was explained by the 
galactorrhea amenorrhea syndrome in longstanding  hypothyroid  
patients. 
Oligomenorrhea in hyperthyroidism may be due to poor 
responsiveness to LH or increase in hormone binding globulins producing 
a decrease in free available estradiol, which in turn may produce 
menstrual abnormalities. Anovulation in hypothyroidism was found in 
77.8%.
2 
This  anovulation can be explained by secondary pituitary 
depression in hypothyroid states which results in cyclic loss of LH surge 
or it may be due to hyperprolactinemia. 
  
  
 
 
 
Table A :- Relation of thyroid function to type of cycle 
Thyroid Profile Types of Cycles Percentage % 
Hypothyroid Anovulatory 
Ovulatory 
77.8% 
22.2% 
Hyperthyroid Anovulatory 
Ovulatory 
63.64% 
36.36% 
Hyperprolactinemia   is  an  important  mechanism  for  producing  
anovulatory cycles  in hypothyroidism. Mechanism of anovulation  in  
hyperthyroid patients was entirely separate as in this study none of the  
patients  had  hyperprolactinemia  among  the  hyperthyroid  patients. 
            In hyperthyroidism there is an increase in testosterone and 
estradiol binding globulins which causes a decrease in unbound fraction 
of these hormones which may cause a lack of feedback inhibition of  
gonadotrophins and thus resulting in an increase in  LH, which can partly 
explain  anovulation. 
Ross Mc Dougall, 1992 stated that ‘there is a clinical impression 
that hypothyroid patients have a bleeding tendency’.
11
 However this is 
seldom a clinical problem. Several case reports describes hypothyroid 
patients with a significant bleeding diathesis in whom the underlying 
cause is not completely defined. The usual finding is similar to Von 
  
 
 
 
Willebrand's disease with low concentration of factor VIII and an 
inhibitor of coagulation". Treatment with thyroxine corrects the  
problem.
16
 
Blum and Blum, 1992, the relationship between subclinical or 
early hypothyroidism and menorrhagia in women with intrauterine 
contraceptive device in situ  and  that  menorrhagia  responds  to 
thyroxine  therapy.
17 
Hypothyroidism can also be in association with acquired Von 
Willebrand's Disease leading to menorrhagia  which  will  resolve 
following treatment  of  hypothyroidism
19
. 
In a study of  189  hypothyroid  women to find out their menstrual 
pattern and fertility status. As many as 91 patients(71.09%) had 
subclinical hypothyroidism; 46.87% had normal menstrual pattern. 
Menstrual aberrations included mainly, oligomenorrhea, hypomenorrhea, 
menorrhagia and secondary amenorrhea. Oligomenorrhea was the 
commonest menstrual abnormality found mainly in early age group 
females. Menorrhagia was common in later age groups.
21
 In this study 
author has commented that ‘as majority of cases are subclinical, It is 
essential to evaluate thyroid function in all women with intractable  
menstrual disorders, infertility and  recurrent pregnancy loss 
21
. 
  
 
 
 
 Leon Speroff 1999, explains menstrual irregularities and bleeding 
problems being common in hypothyroid women. Amenorrhea can be a 
consequence of hypothyroidism either with TRH induced increase in 
prolactin or with normal prolactin levels. He explained the involvement 
of sex hormone binding globulin (SHBG). SHBG is a glycoprotein 
synthesized in liver and contains a single binding site for androgens and 
estrogens. Estrogen and  thyroxine  are stimulatory for its production. 
Free estradiol levels  are increased because of significant  decrease in 
SHBG. The total binding capacity of SHBG will thus influence the 
amount that is free and unbound.  High levels of estrogen and sustained 
availability leads to prolonged period of  amenorrhea  followed  by  acute, 
often  profuse  bleeds  with  excessive  loss  of  blood.
22 
          Jeffcoates (2001), mentioned that hypothyroidism tends to cause 
menorrhagia or polymenorrhea  these symptoms being present in 30-40% 
of cases. Thyroid function should be especially evaluated in cases of 
menorrhagia. Hypothyroidism and hyperthyroidism can both depress 
ovarian and menstrual function. The latter never causes amenorrhea 
unless exophthalmos is present. When hyperthyroidism is associated with 
amenorrhea, it is necessary to recognize that it may be merely a 
manifestation of a pituitary fault which is also the cause of menstrual 
  
 
 
 
upset. Hypothyroidism is associated with an increase in thyrotrophin 
releasing hormone which in turn may be associated with a raised 
prolactin level and hence amenorrhea.
23 
In a study conducted on 213 patients with DUB, menorrhagia  as 
their chief menstrual abnormality, hypothyroidism was detected in 
28.17% of the cases, proliferative  endometrium was seen in majority of 
hypothyroid patients. 78% patients respond to medical line of treatment 
thereby avoiding hormones or surgical intervention. It was also noted that 
45% patients were clinically euthyroid but demonstrated altered 
biochemical levels while 55% patients  had  symptoms/signs/both.  Easy   
fatiguability  was  the  commonest  symptom. 
 Novak S., (2002), mentions both hypothyroidism and 
hyperthyroidism can be associated with abnormal bleeding. With 
hypothyroidism menstrual disturbances, including menorrhagia are 
common. Hyperthyroidism can result in oligomenorrhea and amenorrhea 
and it can also lead to elevated levels of plasma estrogen. Also 
coagulation abnormalities such as Von-Willebrand's disease can have a 
variable clinical picture and may escape diagnosis until the re productive  
years.
25  
  
 
 
 
Control Of Endocrine Function of Ovaries, thyroid, adrenal glands by 
Hypothalamus and pituitary 
 
DYSFUNCTIONAL UTERINE BLEEDING (DUB) AND 
CLASSIFICATION  OF  DUB 
Dysfunctional uterine bleeding is defined by various authors in 
many ways leading to confusion as to, which are the exact entities which 
come under this heading. 
  
 
 
 
NOVAK defines it as "bleeding without a causative uterine lesion 
such as tumor, infection or complications of pregnancy, although 
frequently there may be associated cysts of  the  ovary". 
SUTHERLAND  defines DUB as "Abnormal uterine bleeding 
which is not explained  by any palpable lesions of  the reproductive  
organs".
25 
CROSSEN defines it as "irregular, excessive, scanty or prolonged 
bleeding of endometrial origin, occuring without neoplasia, infection, 
pregnancy, blood dyscrasias, trauma  or hormone  administration".
26,27 
TAYLOR restricts the term DUB to be applied only when all 
possible causes for, excessive or prolonged bleeding have been excluded. 
Such as exclusive approach would tend to eliminate from consideration 
any uterine bleeding for which an etiology has been uncovered.
28 
TELINDE defines DUB as a symptom complex that in absence of 
pregnancy, neoplasm,  infection or intrauterine lesions.
29 
SPEROFF describes DUB variety of bleeding manifestations of 
anovulatory cycles (in absence of pathology or medical illness).
22 
  
 
 
 
JEFFCOATES defines it as "excessive, prolonged, unpatterned  
bleeding from the endometrium unrelated to structural or systemic 
disease and thus other diagnosis must  be  excluded.
23 
DEWHURST defines DUB as "abnormal bleeding from the uterus 
in the absence of  organic  disease of  the genital tract".
1 
DAWN refers it as excessive uterine bleeding where no organic, 
systemic, hematologic  or  pelvic cause  can  be  detected.
30 
Two areas of general agreement can be obtained from these 
sources - first, the necessity to exclude bleeding arising from organic 
disorders of the reproductive tract in order that an entity may qualify as 
DUB. Second,that endocrinological  abnormalities have a significant 
relationship to DUB. 
Adequate clinical examination of abdomen and pelvis, uterine 
curettage, hysteroscopy or atleast an endometrial biopsy are essential to 
exclude organic disease of the uterus. In recurrent severe abnormal 
uterine bleeding repeat curettage should be done to avoid previously 
missed organic disease.
1  
Hence, a provisional diagnosis of DUB is made 
clinically. 
  
  
 
 
 
Table B : - Classification of DUB 
Ovular haemorrhage Anovular  haemorrhage 
• Irregular     ripening      of the 
endometrium 
• Prolonged ripening or irregular 
shedding  of the endometrium 
a) Threshold bleeding 
 
b) Metropathia haemorrhagica. 
Table C:- CLASSIFICATION OF DUB 
The following practical classification of DUB based on etiology 
and clinical features was put forward by Vorys and Neri (1968). 
  
  
 
 
 
Type Cycle Type bleeding Cause  
I Ovulatory 
i) Follicular abnormality 
 
ii) Corpus luteum 
abnormality 
a) Long proliferative phase 
b) Short proliferative phase 
 
a) Insufficiency 
 
b) Prolonged 
1) Long cycles normal bleeding 
2) Short cycles normal bleeding 
 
1) Premature spotting short cycles 
2) Prolonged cycle with prolonged 
excessive bleeding 
Slow development of follicle 
Hypersensitivity of ovary 
 
Irregular ripening of endometrium 
Irregular shedding of 
endometrium 
II Anovulatory a) Cyclic 
 
b) Acyclic 
Normal cycle excessive bleeding 
 
1) Irregular excessive bleeding 
 
2) Irregular scanty Bleeding 
High peak estrogen levels 
proliferative endometrium 
Continuous high estrogen levels 
hyper plastic endometrium 
Continuous low estrogen levels 
atrophic endometrium 
 
  
  
 
 
 
In 1955 Jeffcoate classified the dysfunctional uterine bleeding into 
ovular and anovular types.
23
 
Oligomenorrhea : Infrequent irregular episodes of bleeding, usually 
occurring at  interval  of  more than  35 days. 
Polymenorrhea : Frequent but regular episodes of uterine bleeding 
usually occurring  at  intervals  of  24 days or less. 
Menorrhagia: Uterine bleeding usually excessive and prolonged 
occurring at regular  intervals. 
Menometrorhagia : Uterine bleeding usually excessive and prolonged 
occurring  at  frequent  irregular   intervals. 
Hypomenorhea : Uterine bleeding that is regular but decreased  in 
amount. 
Intermenstrual bleeding : Uterine bleeding usually not excessive 
occuring between  regular  menstrual  periods. 
Metrorhagia - Irregularly timed bleeding. 
 
 
  
 
 
 
 Relationship  Between  Endocrine, Ovarian And 
Endometrial Cycles 
 
 
 
  
 
 
 
PHYSIOLOGY OF MENSTRUATION 
As DUB is a hormonal disorder, knowledge of the normal 
hormonal control of menstruation is useful. Menstruation may be defined 
as a "periodic and cyclical shedding of  progestational  endometrium 
accompanied by loss of blood". It takes places at approximately 28 days  
interval with a range of 21-35 days between the menarche (onset of 
menstruation) and menopause (cessation of menstruation). Menstruation 
is dependent on hormonal control mainly from the hypothalamus, anterior 
pituitary and ovary. 
The first 3-5 days are occupied with menstruation when two third  
of the endometrium is shed. The remaining 23-25 days are divided into 
the follicular and luteal phases or proliferative and secretory phases 
respectively. The follicular phase is characterized by maturation of the 
Graffian Follicle and the consequent production of estrogen hormone 
which brings about proliferation of the endometrium. The luteal phase 
which occurs following ovulation is characterized by the formation of the 
corpus luteum and the production of both estrogen and  progesterone 
which brings about secretory changes  in  the endometrium.
32 
 
  
 
 
 
Ovulation is tuned in relation to the next menstrual period which it 
precedes  by  14±2 days; this means that the luteal phase in the ovary is 
relatively constant in duration whereas the length of  the follicular phase 
varies with the total  length of  the cycle. 
The onset and duration of these phases are determined by a 
cyclical and sequential discharge of gonadotrophins by the hypothalamo-
pituitary system. The gonadotrophins i.e. follicle stimulating hormone 
(FSH) and luteinizing hormone (LH) are produced by the anterior 
pituitary. Their release is mediated  by a  hypothalamic releasing factor - 
LH/FSH-RH (GnRH). 
          The FSH stimulates the Graffian follicle to mature and its action is 
predominant in the  first half of the cycle - the follicular phase. The 
granulosa and the  theca  cells  of the follicle produce increasing amounts 
of  estrogen which reaches a  peak just  before ovulation.  The high levels 
of estrogen in the circulation conditions the pituitary to respond to the 
(GnRH) by secreting LH instead of FSH.  A high level of LH induces 
ovulation and corpus luteum formation with a consequent increase in the 
secretion of progesterone. The output of LH/FSH-RH(GnRH) then 
decreases. It is not known whether progesterone inhibits its release or 
whether the output  of  LH/FSH-RH (GnRH)   is self limiting.  Whatever 
  
 
 
 
the mechanism, the production of the releasing  hormone falls or stops. 
This leads to a drop in LH and degeneration of the corpus luteum. The 
resulting fall in the level of both estrogen and progesterone leads to 
menstruation and stimulates  the  hypothalamus  to  release  GnRH  to 
start  the  next cycle. 
Estrogen, which predominate during the proliferative phase is 
secreted by the follicular cells and it is a very potent steroid, capable of 
producing rapid and significant changes in target tissue (uterus, vagina, 
breast) which depends on their activity to produce a special cytoplasmic 
protein called "estrogen receptor” . Estrogen causes growth and 
proliferation of the cells(stromal and glandular) in the endometrium. 
Experimentally intravenous administration of estrogen causes  prompt  
hyperemia and  rapid  uptake  of  water. 
Progesterone, whose effect prevails in the secretory phase is 
secreted by the corpus luteal cells. Specific receptors for progesterone 
has also been detected in the endometrium. Progesterone helps in 
differentiation of stromal cells either into large predecidual cells or into 
small  endometrial  granulocytes. It  also causes growth of spiral 
arterioles.
32 
 
  
 
 
 
ANOVULATORY BLEEDING
32, 33 
Anovulation or oligo-ovulation is the commonest cause of 
abnormal uterine  bleeding  when  no  organic  cause  has  been  found. 
The characteristic feature is the absence of active corpus luteum 
tissue in the ovary. A follicle ripens but fails to rupture, the ovum dies 
and follicle may go onto cyst formation whether it forms a cyst or not, it 
produces estrogen for time and this act on the uterus  without  being  
opposed  by  progesterone. 
The production may be continuous at a moderate level, or 
intermittently high and low. In either case the uterus responds by 
hypertrophy of its myometrium and endometrium, and the latter may 
become polypoidal. On section the endometrium shows the picture of 
hyperplasia, usually  of  cystic type (SWISS CHEESE)  but  occasionally  
adenomatous. 
Bleeding is  acyclical it is continuous for 2-8 weeks and can be so 
heavy as to threaten  life. In about half the cases it is preceded by a short 
period of amenorrhea which coincides with a continuously high 
production of estrogen by the follicle and this type of clinical picture was 
earlier often labelled as metropathia haemorrhagica. When the granulosa 
cells becomes less active or when the endometrium grows so thick that 
  
 
 
 
the supply of estrogen becomes relatively inadequate, estrogen 
withdrawal bleeding takes place. The bleeding is always painless. On 
examination the uterus feels slightly enlarged and sometimes possible to 
palpate cystic ovaries. A definitive diagnosis is only by histological 
examination of curettings. 
The underlying cause is unknown personally the failure in 
ovulation, reflects an abnormal gonadotrophin stimulus. Behind this there 
is often a hypothalamic and cortical basis, as in the case of other forms of 
dysfunctional bleeding, being mostly seen in nervously tense and  
emotional subjects. It recurs most commonly during the few years 
preceding the menopause, but is occasionally seen in girls aged 12-20 
years. In the latter it shows a strong tendency to  spontaneous  cure. 
PALM COEIN CLASSIFICATION  
• Polyp 
• Adenomyosis 
• Leiomyoma 
• Malignancy  
• Coagulopathy 
• Endocrinal 
• Iatrogenic 
• Not otherwise specified 
  
 
 
 
Initial Approach to Abnormal Uterine Bleeding in Premenopausal 
Patients 
 
  
  
 
 
 
Algorithm for the diagnostic evaluation of abnormal uterine 
bleeding in premenopausal patients. (CBC = complete blood count; β-
HCG = beta human chorionic gonadotropin; OCPs = oral contraceptive 
pills; IUD = intrauterine device; TSH = thyroid-stimulating hormone; LH 
= luteinizing hormone; FSH = follicle-stimulating hormone; DHEA-S = 
dihydroepiandrosterone sulfate). 
THYROID HORMONE PHYSIOLOGY 
THOMAS WHARTON in 1658 gave the thyroid gland its modern 
name (meaning oblong shield) because he believed the function of 
thyroid was to fill vacant spaces and  contribute to the shape and beauty 
of neck, especially in woman.
33
 Since then the endocrinology of thyroid 
hormone have come long way. For unknown reasons, thyroid diseases is 
more common in women than in men, perhaps autoimmune nature of the 
disease is one contributing factor. 
It is situated in the anterior neck and consists of two pear shaped 
lobes extending to 6
th 
tracheal ring. Isthmus joins the medial aspect of the 
lobes extends over the second to fourth tracheal ring. Superiorly extends 
to thyroid cartilage. In adults thyroid weighs approximately  20g while in 
newborn 1.5g which increases progressively with age/size.
16 
  
 
 
 
The vascular supply to the thyroid is derived from the superior and 
inferior  thyroidal  arteries, venous blood drains through thyroidal veins 
into the external jugular vein. Lymphatics drain into the internal jugular 
Lymph Node (Becker). 
A) SYNTHESIS OF THYROID HORMONE AND CIRCULATION:
34 
The functional unit of thyroid is the follicle consisting an outer 
layer of follicular cells surrounding the central mass of colloid. 
Thyroxine structure was determined by Harrington and Barger in 
1927 and triiodothyronine  by Gross, PittRivers and Roche et al in 1952. 
a)      Iodine transport : 
Thyroid hormone synthesis depend in large part on an adequate 
supply of iodine in diet which is absorbed as iodide in small intestine and 
then actively transported into follicular cells. This happens under TSH 
(thyroid stimulating hormone) effect. Anions such as bromide, 
thiocyanate (SCNT), perchlorate (CIO4) and pertechnetate (Tc04) inhibit 
it. The ATPase  dependent sodium-iodide cotransporter or symporter has 
been isolated and cloned.
35 
This trapping by the symporter is rate limting thyroid hormone 
synthesis which can move iodide 30 fold over blood concentrations. 
  
 
 
 
SYNTHESIS, STORAGE AND SECRETION OF THYROID 
HORMONE 
 
b) Organification : 
Iodide ions transported into the thyroid cell are oxidized before 
being used for iodinating tyrosyl residue present in the thyroglobulin (Tg) 
molecules. This process is called organification takes place at the apex 
and requires enzyme thyroid peroxidase (TPO). 
  
 
 
 
The decrease in peroxidase activity and organification that follows 
iodine excess, known as WOLFF CHAIKOFF EFFECT may protect 
against hyperthyroidism.
36 
c) Coupling : 
Iodination of the tyrosyl residue within Tg involves substitution on 
the tyrosyl  ring.If one iodine replaces a hydrogen then monoiodotyrosine 
(MIT) and if two  then  Diiodotyrosine(DIT) is formed. The MIT/DIT 
ratio depends on iodine  availability  (during  iodine  deficiency  MIT > 
DIT). 
The iodothyronines are formed by coupling of two DITs  to form 
T4 and one MIT and DIT to form T3.  Reverse T3 is a biologically - 
inactive form and is formed by removal of an  iodine from the 
nonphenolic ring of T4. 
In normal adults about one third of the T4 secreted each day is 
converted in peripheral tissues to T3 (largely in liver and kidney) and 
around 40% to reverse T3. However the secretion of  T4 is 20 times the 
rate of T3 (Speroff).
22 
 
 
  
 
 
 
BINDING PROTEINS: 
T4 and T3 are reversibly bound to several proteins synthesized by 
the liver. Approximately 70% of thyroid hormones are bound to 
Thyroxine binding globulin(TBG)  which is therefore the major 
determining factor in the total thyroid hormone concentration in the 
circulation. Remaining 30% is bound to thyroxine binding prealbumin 
(Transthyretin) (TTR) and albumin. The binding proteins have a greater 
affinity for T4 and thus allows T3 to have greater entry into cells. TBG is 
synthesized in the liver and this synthesis is increased by estrogens.
37 
B) REGULATION OF THYROID HORMONE : 
Thyroid hormone regulation is directed through the neuroendocrine 
– hypothalamic pituitary - thyroid peripheral tissue axis. B.R. Walker and 
AD Toft explains (In Davidson text book medicine) that production of T3 
and T4 in the thyroid is stimulated by TSH (thyrotrophin ,thyroid  
stimulating hormone), a glycoprotein released from the thyrotroph cells 
of the anterior pituitary in response to the hypothalamic tripeptide, TRH 
(thyrotrophin releasing hormone). A circadian rhythm of TSH secretion 
can be demonstrated with a peak at 0100 hrs and through at 1100 hrs, but 
the variation is small and does not influence the timing of blood sampling 
when assessing thyroid function. 
  
 
 
 
There is a negative feedback of thyroid hormones on the 
thyrotrophs such that in hyperthyroidism, when plasma concentrations of 
T3 and T4 are raised TSH secretion is  suppressed  and in 
hypothyroidism due to disease of the thyroid gland low T3  and T4  are  
associated  with high circulating TSH levels. 
The anterior pituitary is very sensitive to minor changes in thyroid 
hormone levels within the normal range. The combination of 'normal' T3  
and T4 and suppressed or raised TSH is known subclinical 
hyperthyroidism and subclinical hypothyroidism respectively. 
Estrogen increases the TRH receptor content of the pituitary hence 
the TSH response to TRH  is greater in women. TRH also stimulate 
prolactin secretion by the pituitary. 
C) THYROID FUNCTION TEST : 
The determination of circulating levels of thyroid hormones is 
essential for an accurate assessment of the functional status of 
patients.For many years Serum thyroxine (T4) concentration was  the 
most useful first line test.  Serum T4 is determined almost exclusively by 
RIA, values in euthyroid patients ranges 5-12 mcg/dl. In general (except 
T3 thyrotoxicosis etc.,) the value of  T3 (serum triiodothyronine) parallel 
  
 
 
 
with T4 level and ranges in healthy subject being 80-200ng/dl. Reverse 
T3 (rT3) varies from 10-60 ng/dl.  rT3 values are often elevated in 
nonthyroidal  illness.
39,34 
To assess the patients true metabolic status estimation of the 
concentration of free T4 or free T3 - the "active" hormones is advisable 
by equilibrium dialysis, the most precise method, (which may not be 
available in all centers).
40 
Serum thyrotropin (thyroid stimulating hormone, TSH) has been a 
reliable indicator of primary hypothyroidism with levels rising even when 
thyroid deficiency is mild and T4 levels still normal.
34
 Although RIAs 
were developed that could detect TSH concentrations of 0.1 to 0.3 
mcg/ml, it was achieved by extensive purification. Commercially 
available RIAs have not provided quantitative values below 1 mIU/l, 
many second - generation assays detect TSH in the range of 0.1 to 0.5 
mIU/l and third generation assay have an even 10 fold greater functional 
sensitivity.
41,42,43,44
 
Extremely sensitive (fourth generation) assays can detect TSH 
levels = 0.004 mU/l but for practical purposes, assay Sensitive to = 0.1 
mU/l are sufficient. The widespread availability of TSH Radio-
immunoassay has rendered the TRH stimulation test virtually obsolete.
45 
  
 
 
 
Table D: SYMPTOMS AND SIGNS RELEVANT TO 
DISORDERED THYROID  FUNCTION:  (Leonard Wartofsky, 
Becker's thyroid diseases) 
 
Body system Hyperthyroidism Hypothyroidism 
Central nervous 
system 
Irritability, anxiety, 
depression, insomnia, 
agitation, heat intolerance 
Memory  loss, somnolency 
depression, cold  
intolerance. 
Eyes, ears, nose 
and throat 
Eye grittiness, tearing, 
Exopthalmos 
Periorbital edema, 
hoarseness 
Cardio 
respiratory 
Dyspnea, palpitations 
Tachycardia 
Chest pain, peripheral 
edema, Bradycardia 
Gastro intestinal Increased appetite, weight 
loss, dysphagia, diarrhea 
Decreased appetite, weight 
gain, constipation 
Skin Increased sweating, hair 
loss, pruritus 
Decreased sweating, dry 
coarse skin, coarse hair, 
hair loss 
Genitourinary Polyuria, polydipsia, 
amenorrhea, decreased 
libido, impotence 
Menorrhagia, decreased  
libido 
Musculo-skeletal Fatigue, muscle weakness, 
tremor 
Fatigue, arthralgias, 
myalgias 
 
  
 
 
 
Features of hyper and  hypothyroidism 
 
 
 
  
  
 
 
 
PHYSICAL EXAMINATION RELATED TO THYROID 
DYSFUNCTION 
General  Survey 
1. Build and nutrition- In thyrotoxicosis the patient is usually thin and 
underweight. Patient have excessive sweating moist skin with 
muscle wasting, in hypothyroidism reverse is true (dry skin, obese). 
2. Facies - In thyrotoxicosis one can see the facial expression of 
excitement, tension, nervousness with or without variable degree 
of exopthalmos.  Mask like  puffy face  is  seen in hypothyroidism. 
3. Mental State and intelligence- Hypothyroid patients are naturally 
dull with  low  intelligence. 
4. Pulse rate especially sleeping pulse rate is very useful index to 
determine the degree of  thyrotoxicosis.  Bradycardia  may be 
present in hypothyroid state. 
5. Eye Signs should be appreciated and looked for in primary 
thyrotoxicosis. 
"Lid retraction" is when upper lid is higher than normal and is 
different from "Lid lag" where the upper eyelid cannot keep pace 
with the eyeball when it looks down. Both these signs are NOT 
exopthalmos. 
  
 
 
 
Exopthalmos  develops  when eyeball is pushed  forwards due to 
increase in fat or edema  or cellular infiltration in the retro-orbital 
space, the eyelids are retracted, weakness of  ocular muscles 
(Ophthalmoplegia)  was looked for by examining their movements.  
Chemosis (edema) of conjunctiva may be present. 
Local Examination 
1.  Inspection - Normal thyroid gland is not obvious on inspection. In 
short neck, obese people, Pizzillo's Method is used to render 
inspection easier. A thyroid swelling may be uniform 
(physiological goiter, colloid goiter, hashimoto's disease) or 
isolated nodules. A thyroid gland moves on deglutition as the 
thyroid gland is fixed to the larynx. Congestion of face and distress 
become evident in case of retrosternal goiter due to obstruction of 
the great veins at the thoracic inlet when patient is asked to raise  
both the arms over his head. 
2. Palpation - The gland should always be palpated with the  patients  
neck slightly flexed  from behind and from the front.  Palpation of 
each lobe is best carried out from the front.  The surface and 
consistency is observed whether smooth ( primary thyrotoxicosis or  
colloid goiter) or bosselated (multinodular goiter).  Mobility of 
  
 
 
 
gland should be noted.  Palpation of cervical lymph node is done  
routinely to rule out any underlying malignancy. 
3. Percussion is done over manubrium sterni to exclude the presence 
of a retrosternal  goiter. 
4. Auscultation - In primary toxic goiter a systolic bruit may be heard 
over the goiter  due  to  increased  vascularity(Thyroid Bruit). 
5. Measurement of  the  circumference of the neck at the most 
prominent part of   the  swelling may be taken at intervals. 
Table E:- PATTERN OF THYROID FUNCTION TEST RESULTS 
IN PATIENTS  WITH  THYROID  DISEASE  (DAVIDSON'S)
35
 
Type of disease T4 T3 TSH 
Conventional hyperthyroidism 
(95% of cases) 
Raised Raised Undetectable 
T3 hyperthyroidism       (5% of 
cases) 
Normal
1 
Raised Undetectable 
Subclinical hyperthyroidism Normal
1 
Normal
1 
Undetectable 
Primary hypothyroidism Low Not indicated
2
 Raised (usually 
>20m U/L) 
Subclinical hypothyroidism Normal
3 
Not indicated
2
 Raised 
Secondary hypothyroidism i.e. 
pituitary or hypothalamic 
disease 
Low Not 
indicated
2 
Usually 
undetectable
4 
Non thyroidal illness Raised Low, normal 
or raised
5 
Usually 
undetectable. 
 
  
 
 
 
1) Usually upper part of reference range 
2) Measurement of T3 is not a sensitive indicator of hypothyroidism 
and should not be requested. 
3) Usually lower part of reference range 
4) May be normal or even slightly raised due to the production of 
immune reactive forms of  TSH  which have no biological activity. 
5) Depending on the assay system. 
  
  
 
 
 
MATERIAL AND METHODS 
Present study aimed to establish the role of thyroid dysfunctions in 
relation to menstrual disturbances. This study was carried out in the 
department of Obstetrics & Gynecology, Coimbatore Medical College, 
Coimbatore. 100 women who were given clinically the provisional 
diagnosis as dysfunctional  uterine bleeding during the period from 
November 2012 to October 2013 were  selected  for  the  study. 
INCLUSION CRITERIA 
1) All cases provisionally diagnosed to have  dysfunctional  uterine 
bleeding from puberty to premenopausal age groups. 
2) All patients with  major complaints of  menstrual disturbances. e.g; 
menorrhagia , polymenorrhea , polymenorrhagia, metropathia 
hemorrhagica,metrorrhagia,oligo- and hypomenorrhea. 
EXCLUSION CRITERIA 
1) Patients who were on drugs or hormones , IUCD users.  
2) Patients with history of  bleeding disorders. 
3) Patients with demonstrable organic disease of  reproductive tract. 
  
 
 
 
METHOD: 
 A detailed history with special references to age and bleeding 
pattern 
 Onset, duration and amount of bleeding complaints related to 
thyroid dysfunction noted in detail. 
 A detailed history of thyroid disorders (hypo and hyperthyroidism) 
is obtained. 
 A thorough clinical examination including general physical 
examination, neck examination, gynaecological and systemic 
examination with special reference to thyroid dysfunction. 
 All patients are subjected to routine investigations like 
haemoglobin percentage, blood counts, urine examination for 
albumin, sugar and microscopy. 
 Bleeding time and clotting time performed for all patients. 
 All patients subjected to thyroid function test in her sera (T3, T4 & 
TSH.) 
  
 
 
 
 Thyroid stimulating hormone (TSH) assay done by ultra sensitive 
sandwich chemi luminescent immuno assay and T3 & T4 measured 
by competitive chemi luminescent immuno assay. 
Reference values 
Test name / units (reference range) 
Thyroid stimulating hormone (TSH) / m IU/ml  (0.40  -5.6) 
Triiodothyronine ( T3) 61-200 ng/dl  
Thyroxine ( T 4)  / (4.6 - 12)  µg/ml                                     
  T3, T4 and TSH measured and patients are grouped into four categories, 
• EUTHYROID 
• SUBCLINICAL HYPOTHYROID 
• HYPOTHYROID 
• HYPERTHYROID 
Patients found to have thyroid dysfunction are referred to  
physician for further management. 
 
  
 
 
 
OBSERVATION AND RESULTS 
 
Dysfunctional uterine bleeding is one of the most frequently 
encountered condition  in  gynecological practice. 
The following few pages  are tables which will give a descriptive 
analysis  of  the  age distribution, the parity distribution, symptomatic 
distribution  of DUB  and its association  with  thyroid dysfunction. 
The total number of patients studied was 100 from Nov 2012 - 
October 2013. 
TABLE 1 
DISTRIBUTION OF PATIENTS ACCORDING TO AGE 
Age group (years) No. of cases 
< 20 23 
21-30 30 
31-40 36 
41-45 11 
TOTAL 100 
 
According to above table maximum number of patients in the study 
group belongs  to the  age  group of  31-40 years (36% ),between age 
group  41-45 years  11 cases were seen  (11%). 
  
 
 
 
Graph 1 
DISTRIBUTION OF PATIENTS ACCORDING TO AGE 
 
Table 2 
DISTRIBUTION OF PATIENTS ACCORDING TO PARITY 
Parity No. of Patients Percentage 
Unmarried 25 25% 
0 6 6% 
1 9 9% 
2 22 22% 
3 21 21% 
4 10 10% 
5 7 7% 
100 100 100% 
  
 
 
 
The above column shows relationship of DUB with parity.  Among 
100 cases of  DUB  25 patients were unmarried , 6 patients were 
nulliparous ,9   patients were  para 1, 22 patients were para 2, 21patients 
were  para 3, 10 patients were para 4,  7 patients were para 5.  In this 
study maximum number of patients were unmarried (25%) and  minimum 
number of patient presenting as clinical DUB cases were of nulliparous. 
 
GRAPH 2 :  
Distribution of patients according to parity 
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TABLE 3 : 
DISTRIBUTION OF PATIENTS ACCORDING TO  SYMPTOMS 
Type of bleeding No. of cases 
Acyclical (MPH) 15 
Hypomenorrhea 5 
Menorrhagia 32 
Metrorrhagia 3 
Oligomenorrhea 19 
Polymenorrhagia 18 
Polymenorrhea 8 
Total 100 
 
GRAPH  3 : DISTRIBUTION OF PATIENTS ACCORDING TO  
BLEEDING   PATTERN 
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TABLE 4 
DISTRIBUTION OF PATIENTS ACCORDING TO AGE GROUPS AND BLEEDING PATTERN 
 
Age in 
years 
No. Of 
cases 
Acyclical 
(MPH) 
Hypo 
menorrhea 
Menorrhagia Metrorrhagia Oligo 
menorrhea 
Poly 
menorrhagia 
Poly 
menorrhea 
< 20 23 5 21.7% 1 4.3% 9 39.1% 1 4.3% 4 17.3% 3 13.04 % 0 0 
21 - 30 30 3 10% 3 13.04% 11 36.6% 0 0 7 23.3% 1 3.3% 5 16.6% 
31 - 40 36 5 13.8% 1 2.7% 10 27.7% 2 5.5% 7 19.4% 3 8.3% 8 22.2% 
41 -50 11 2 18.18% 0 0 2 18% 0 0 1 9% 1 9% 5 45.4% 
 100 15  5  32  3  19  8  18  
 
  
 
 
 
          The above column shows 100 patients who came with the 
complaint of different bleeding  pattern. Commonest was menorrhagia 
32%. Among others 15% of cases presented with Acyclical (MPH), 19% 
with Oligomenorrhea, 18% had polymenorrhagia, 8% had  
polymenorrhea, 5% had Hypomenorrhea, 3% had metrorrhagia. 
Maximum patients were seen with complaint of menorrhagia, following 
which oligomenorrhea   seen. 
Patients with age less than and equal to 20 years, most common 
bleeding pattern was menorrhagia (39.1%). Followed with acyclical 
metropathia(21.7%).   Oligomenorrhea  was  present in 17.3% of the 
cases. 
Similarly in age groups- 21-30 years and 31 - 40 years the 
commonest bleeding pattern was menorrhagia. Whereas in patients with 
age >41 had polymenorrhea as their commonest  bleeding pattern. 
 
  
  
 
 
 
TABLE 5 :  
DISTRIBUTION OF PATIENTS ACCORDING TO  
THYROID FUNCTION. 
 
Thyroid function No. of cases Percentage 
Euthyroid 77 77% 
Hypothyroid 7 7% 
Subclinical Hypothyroid 13 13% 
Hyper thyroid 3 3% 
Total 100 100% 
 
According to this table maximum number of apparently normal 
patients with DUB belonged to the category of subclinical 
hypothyroidism (13%).  Hormonal levels  revealing  profound 
hypothyroidism in patients without any symptoms was present in only 7 
% of cases. 3% of cases   had hyperthyroidism though they were 
clinically normal. 
  
  
 
 
 
GRAPH 4 :  
Thyroid Function 
Euthyroid       Hypothyroid        Subclinical          Hyperthyroid 
Table  6 : THYROID DYSFUNCTION IN RELATION TO PARITY 
Parity 
No. 
cases 
Euthyroid TDF 
Total 
Thyroid 
dysfunction 
Percentage 
Unmarried 25 19 3 3 - 6 24% 
0 6 4 1 1 - 2 33% 
1 9 8 0 0 1 1 11% 
2 22 17 1 3 1 5 22.7% 
3 21 16 2 3 0 5 23.8% 
4 10 7 0 2 1 3 30% 
5 7 6 0 1 0 1 14.2% 
Total 100  7 13 3 23 100% 
  
 
 
 
This table shows the relationship of parity to thyroid dysfunction in 
patients with provisionally  diagnosed DUB. Thyroid dysfunction was 
commonest among nulliparous patients about 33% and next common 
among patients who were para 4, i.e, 30%.  24% of unmarried patients  
had thyroid dysfunction. Thyroid dysfunction was least common in 
patients who were primipara only (11%). This shows that thyroid 
dysfunction can lead to infertility (nulliparous state) . The difference in 
thyroid functioning in individual type of parity is not statistically 
significant.  Chi-square =0.62   ;   P=0.89(NS) . 
 
  GRAPH 5 :  
Thyroid dysfunction in relation to  parity 
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Table  7:     
THYROID DYSFUNCTION IN DIFFERENT AGE GROUPS. 
AGE 
No. of 
cases 
Euthyroid 
Hypo 
Thyroid 
Sub 
hypothyroid 
Hyper 
thyroid 
Total 
Thyroid 
Dysfunction 
Percentage 
< 20 23 17 3 3 0 6 26% 
21 -30 30 26 1 1 2 4 13.3% 
31 –40 36 26 1 8 1 10 27.7% 
41 - 45 11 8 2 1 0 3 27.2% 
Total 100 77 7 13 3 23 23% 
 
This table shows the relationship of thyroid dysfunction to different 
age groups. Thyroid  dysfunction was commonest in the age group 
between 31-40 years - 27.7%.  Followed with  27.2%  among patients 
between 41-45 years.  26% of patients less than 20 years  showed  thyroid  
dysfunction. 
Thyroid dysfunction was least common in patients between 21-30  
years- 13% .This shows that thyroid dysfunction becomes common as 
patients age advances and in  this study it is commonly seen in patients 
more than 30 years.  Thyroid dysfunction is least  common in patients 
between 20-30 years of age. The difference in thyroid functioning in 
individual age groups is not statistically significant .  Chi square=2.28   
;P=0.52(NS) 
  
 
 
 
Graph 6 :  
Thyroid Dysfunction 
 
 
Table  8:  Pattern of Bleeding 
Types of 
Bleeding 
No.of 
cases 
Euthyroid 
Hypo 
thyroid 
Subhypo 
thyroid 
hyperthyroid 
 
Acylical (MPH) 15 10 3 2  
Hypomenorrhea 5 5 - -  
Menorrhagia 32 24 2 6  
Metrorrhagia 3 3 - -  
Oligomenorrhea 19 13 2 1 3 
Polymenorrhagia 18 17 - 1  
Polymenorrhea 8 5 - 3  
Total 100 77 7 13 3 
  
 
 
 
This table shows how thyroid dysfunction which can be 
hypothyroidism subclinical hypothyroidism or hyperthyroidism is related 
to various types of bleeding abnormalities. Thyroid dysfunction was 
commonest in patients with polymenorrhea - 37.5%, next common in 
patients  with acyclical metropathia - 33%  followed with in patients with 
oligomenorrhea - 31.5%.  Patients with menorrhagia had thyroid 
dysfunction in 25% of cases. Thyroid dysfunction  was  least common in 
patients with polymenorrhagia (5.5% ) and absent in patients with  
metrorrhagia. 
The difference in thyroid functioning in individual type of DUB is 
not statistically  significant   Chi-square=7.53  ;P=0.27(NS) . 
  
  
 
 
 
Table 9: BLEEDING PATTERNS IN HYPOTHYROIDISM AND 
HYPERTHYROIDISM 
Types of 
Bleeding 
No.of 
Cases 
Eu 
thyroid 
%              
 
Hypo 
thyroid 
% 
Subclinical 
hypothyroid 
% 
Hyper 
thyroid 
(%) 
Acylical (MPH) 15 10 66.6% 3 20% 2 13.3%  
Hypomenorrhea 5 5 100% -  -   
Menorrhagia 32 24 75% 2 6.2% 6 18.75%  
Metrorrhagia 3 3 100% -  -   
Oligomenorrhea 19 13 68.4% 2 10.5% 1 5.2% 3 (15%) 
Polymenorrhagia       18 17 94.4% -  1 5.5%  
Polymenorrhea 8 5 62.5% -  3 37.5%  
 
This table shows the relationship of hypothyroidism, subclinical 
hypothyroidism  and  hyperthyroidism to the different types of clinically 
diagnosed cases of DUB.  In acyclical MPH, patients were hypothyroid in 
20% of cases and 13.3%  of  patients  had  subclinical hypothyroidism.  
Whereas in patients with menorrhagia only 6.2%  of  patients  had  
hypothyroidism and 18.75% of patients had subclinical hypothyroidism. 
Patients  with  oligomenorrhea had hyperthyroidism in 15% of patients, 
hypothyroidism in 10.5% of patients  and subclinical hypothyroidism in 
5.2%.  In polymenorrhea patients 37.5% of cases had subclinical 
hypothyroidism. 
  
 
 
 
So, patients who were subclinically hypothyroid were maximally 
presenting as  polymenorrhea (37.5%) and menorrhagia (18.75%) and 
only 5.25%of patients  had oligomenorrhea. Patient who were 
hypothyroid were predominantly having  acyclical  metropathia(MPH) 
20% and 10.5% of patients were having oligomenorrhea. 
On the other hand patients who were hyperthyroid were 
exclusively presenting as oligomenorrhea. Subclinical hypothyroid 
patients have polymenorrhea  and  menorrhagia as  their  commonest 
bleeding  pattern. 
 
GRAPH 7 :  
Bleeding Pattern in Hypothyroidism and Hyperthyroidism 
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TABLE 10  
TSH LEVELS AND DIFFERENT BLEEDING PATTERNS 
 
TSH 
Level 
No. Of 
cases 
Acyclical 
(MPH) 
Hypo 
menorrhea 
Menorrhagia Metrorrhagia Oligo 
menorrhea 
Poly 
menorrhagia 
Poly 
menorrhea 
<0.39 3 0        3 100%    0 
0.4 - 5.6  
(Normal Range) 
77 10  5  24  3  13  5  17  
5.7 <50.0 14 3 21% 0  6 42%   1 7.1% 3 21.4% 1  
> 50 6 2 33.3% 0  2 33.3%   2 33.3%     
  
 
 
 
Thyroid Dysfunction 
This table shows the relation of TSH levels to different types of  
bleeding patterns.  Patients  with  TSH levels  <  0.39  all  of them  
presented with  symptoms of  oligomenorrhea. 
Patients with TSH levels moderately elevated 5.7 - <50.0 as seen in 
subclinical hypothyroidism, 42% of patients presented with menorrhagia,  
21.45 % of patients presented with  polymenorrhea and 21% presented 
with acyclical MPH. In this group maximum number of patients 
presented with menorrhagia. Patients with TSH levels profoundly 
elevated i.e,>50 had acyclical MPH in 33.% of cases, menorrhagia in 
33.3% of cases and oligomenorrhea in 33.3%  of cases. So in this table it 
is seen that oligomenorrhea  was seen in patients with TSH value <0.39  
or when profoundly high i.e, >50 on the other hand menorrhagia  was 
mostly seen in  patients with TSH value (5.7 - <50)  moderately elevated. 
Patients with T3 levels  <  60 had  acyclical MPH in 50% of   the 
patients, 33% of patients had oligomenorrhea and 17% had menorrhagia. 
Where the T3 levels >200  all patients had oligomenorrhea. Only 8%  of  
the total  No. of patients showed abnormal T3 levels compared to  23% of  
patients who showed abnormal TSH levels. 
  
 
 
 
Patients with T4 level < 4.5 equal incidence of ayclical  MPH, 
menorrhagia  and  oligomenorrhea (33.3%) each. 
Patients with  T4 levels > 12 had  predominantly oligomenorrhea 
as their complaints  (66%).  Only 12% of the total number of patients 
showed abnormal T4 levels compared to 23%  of patients who showed 
abnormal TSH levels. 
 
  
  
 
 
 
DISCUSSION 
 
Thyroid dysfunction is marked by large number of menstrual 
aberrations. 
In the present study patients were taken from all age groups which 
included less than 20years, (21-30 years), 31-40 years and 40-45 years 
and maximum number of patients belonged in the age group of 31-40 
years.  In author's study (Charusheela D. Doifode et al 2001) also 
maximum number of patients belonged in age group 31-40 years. 
In the present study patients with clinical signs and symptoms of 
thyroid dysfunction were included, also in author's study all patients with 
menstrual aberrations irrespective of the presence of signs and symptoms 
of thyroid dysfunction were included. 
Patients with organic lesions of genital tract, drug (hormone) 
intake, bleeding disorders,  IUD users were excluded from the present 
study and also from the authors study  ( Charusheela D. Doifode  
Kalpana  Fernandes). 
 
  
 
 
 
Present study groups ranged patients according to parity as 
unmarried, nullipara, para1,para 2, para 3, para 4, para 5 and above. 
Similarly author's study had also grouped  parity into  unmarried, 
nullipara, para 1, para 2, para 3, para 4 and more. 
Table 11 : Parity  and Thyroid  Dysfunction 
Parity  
Present Study Author's Study 
(C.D.Doifode et al 
2001) 
No.of patients 
with TDF 
Percentage 
Unmarried 6 26% 9 
0 2 8.6% 4 
1 1 4.34% 20 
2 5 21.7% 9 
3 5 21.7% 12 
4 and above 4 17.3% 6 
This table compares the relationship of parity with thyroid 
dysfunction among patients  with DUB (diagnosed clinically) in the 
present study and in the author's study. 
In the present study 26% of unmarried patients had thyroid 
dysfunction and in Author's study 15% of unmarried patients had thyroid 
dysfunction. In the present study thyroid dysfunction was 8.6% among 
  
 
 
 
nulliparous patients as compared to authors study which showed 6.67%. 
In the present study patients with para1, only 4.34% of them had thyroid 
dysfunction  but in author's study thyroid dysfunction was present in 
33.33% of patients with para 1. 
Maximum number of patients with thyroid dysfunction were 
unmarried in the present study as compared to the author's study, where 
maximum number of patients with thyroid dysfunction  belonged to 
para1. The present study shows a slightly higher  rate  of thyroid 
dysfunction in nulliparous women (8.6%) as compared to the author's 
study i.e., (6.67%). 
Table 12:-  
Age pattern in DUB with thyroid dysfunction. 
Age in years 
Present Study 
Author's study 
(C.D.Doifode et 
al 2001) 
No. of patients 
with TDF 
Percentage 
No. of patients 
with TDF 
Less than 20 6 26% 7 
21-30 4 17.39% 10 
31-40 10 43.4% 29 
More than 40 3 13.04% 14 
 
  
 
 
 
This table compares the relationship of age patterns with thyroid 
dysfunction among patients with DUB in the present study and in 
Author's (C.D.Doifode et al 2001) study. From this table it is noted that 
thyroid dysfunction was commonest in the age group (31-40 years), both 
in the present study and also in the author's study. 26% of patients with 
thyroid dysfunction  were from the group of patients with DUB who were 
less than 20 years in the present study as compared to only 11.67% of  
patients with thyroid dysfunction were from this group in  author's study 
(C.D. Doifode et al).  23.33% of patients with thyroid dysfunction 
belonged to age  group above 40 years in author's study as compared to 
13.04% of patients with  thyroid dysfunction  belonged to this age group 
(above 40) in present study. 
          In both the studies the commonest complaint was menorrhagia. In 
the author's study (C.D.Doifode et al 2001)  60 patients  out of  213 
patients showed  their thyroid dysfunction as hypothyroidism (either 
subclinical or profound)  author's study had  no case of hyperthyroidism. 
Even in the present study, patients with complaints of menorrhagia, 
metropathia, polymenorrhea, polymenorrhagia and metrorrhagia showed 
their thyroid dysfunction as hypothyroidism  either subclinical or 
profound. 
  
 
 
 
          In the present study 100 cases were taken with the complaint of 
abnormal menstruation. Cases of metropathia(acyclical MPH) 
menorrhagia, polymenorrhagia, polymenorrhea, metrorrhagia, 
oligomenorrhea, hypomenorrhea were are included in this study. 
In the author's study 213 cases of clinically diagnosed DUB were 
taken. Patients with oligomenorrhea, hypomenorrhea, and polymenorrhea 
were excluded in author's study. 
In both the studies the commonest complaint was menorrhagia. 
In the author's study (C.D.Doifode et al 2001) 60 patients out of 
213 patients showed their thyroid dysfunction as hypothyroidism (either 
subclinical or profound) author's study  had  no case of  hyperthyroidism. 
Even in the present study, patients with complaints of menorrhagia, 
metropathia, polymenorrhea, polymenorrhagia and metrorrhagia showed 
their thyroid dysfunction  as  hypothyroidism either subclinical or 
profound. 
In the authors study patients with clinical signs and symptoms of 
hypothyroidism were also included, where as in the present study patient 
with clinically diagnosed DUB with any  sign or symptom of 
hypothyroidism were excluded. 
  
 
 
 
In the present study hypothyroidism was the commonest (i.e., 20%) 
thyroid dysfunction  seen in patient with all the seven different types of 
menstrual disturbances. In the following table the commonest menstrual 
disturbances in hypothyroidism is shown in the present study and author's 
study (C.D.Doifode et al 2001). 
In the present study hypothyroidism was the commonest (i.e., 20%) 
thyroid dysfunction  seen in patient with all the seven different types of 
menstrual disturbances. In the following table the commonest menstrual 
disturbances in hypothyroidism is shown in the present  study and  
author's study  (C.D.Doifode et al 2001). 
Table 13:- 
MENSTRUAL PATTERN IN HYPOTHYROID PATIENTS 
Bleeding 
Pattern 
Present Study 
Author's study 
(C.D.Doifode et al 2001 ) 
Acyclical Metropathia 5 25% 4 
Menorrhagia 8 40% 38 
Polymenorrhagia 1 5% 14 
Metrorrhagia 0 - 4 
Oligomenorrhea 3 15% - 
Polymenorrhea 3 15% - 
Hypomenorrhea 0 - - 
Total Hypothyroid Patients 20  60 
  
 
 
 
The type of menstrual abnormality commonly seen in 
hypothyroidism was menorrhagia (63.33%) in author's study. 
Menorrhagia was the commonest menstrual abnormality even in the  
present  study  i.e, 40%. 
Polymenorrhagia was the next common menstrual abnormality 
23.33%  in the author's study. Author's study had excluded cases of 
polymenorrhea. In the present study Polymenorrhea and  
polymenorrhagia both together was the menstrual abnormality in 20% of 
hypothyroid cases. 
Author had excluded cases of oligomenorrhea. In the present study 
oligomenorrhea was the  menstrual pattern in 15% of hypothyroid patient. 
This table shows the type of menstrual abnormality commonly seen 
in hypothyroidism according  to Various authors. 
Table 14:- Menorrhagia in Hypothyroidism 
Authors Menorrhagia 
E.D.Doifode et al 2001 63.3% 
Singh et al 1990 44.4% 
Willansky and Bernard (1989) 100% 
Present study 40% 
  
 
 
 
Subclinical hypothyroidism is diagnosed in cases with normal 
levels of T3 and T4 [ low normal levels] and raised TSH levels i.e., 
(Slightly raised). In the table below cases with menorrhagia who were 
having subclinical hypothyroidism in the present study were compared  
with  Author's study (Douglas L et al 1989). 
Table 15:- Subclinical Hypothyroidism in menorrhagic patients. 
Study 
Subclinical Hypothyroid Cases in 
menorrhagic patients 
Author's Study  
(DouglasL) et al 1989) 
15 
Present Study 6 
Subclinical hypothyroidism was seen in 22.3% of cases with 
menorrhagia in authors  study.(Douglas L. et al., 1989) 
Similarly in present study subclinical hypothyroidism was seen in 
18.75% of cases with menorrhagia. The incidence of subclinical 
hypothyroidism was similar in present study and author's study (Douglas 
L. et al 1989). 
In the present study 9 cases of menorrhagia in age group < 20 were 
studied out of which 2 cases had hypothyroidism. In author's study 
(Jayadev Mukherji et al 1986), 70 cases of  menorrhagia cases were 
studied < 20 years, 5 out of which patients were hypothyroid. 
  
 
 
 
Table 16:- Hypothyroidism in menorrhagia cases  < 20 years of age 
Study 
Subclinical Hypothyroid 
othyroidism 
Hypothyroidism 
Author's Study (Jayadev 
mukherji et al) 1986) 
4.2% 2.8% 
Present study 11% 11% 
 
In the present study subclinical hypothyroidism was seen in 
menorrhagia  patients (<20year)  in 11% of cases. In author's study 
subclinical hypothyroidism was seen  in 4.28%of  menorrhagia  patients  
<20 years. 
In the present study there were total 19 cases of oligomenorrhea in 
which 4 cases were from patients <20 years, 7 cases were patients 
between 21-30 years 7 cases were patients between  31-40 years and 1 
case was patient above 40 years. 
In the author's study (Kalyani Mukherjee et al 1983), 10 cases of 
oligomenorrhea were  taken, age ranging between 25-39 years mean age 
being (31.7+2.8) years. 
  
  
 
 
 
Table 17:- Oligomenorrhea and Thyroid dysfunction. 
Study 
No. of 
Cases 
Hypo 
thyroid 
% 
Hyper 
Thyroid 
% 
Total % of 
Thyroid 
Dysfunction 
Author's Study 
(Kalyani Mukherjee) 
et al 1983) 
10 8 80% 
  
80% 
Present study 19 3 15.3% 3 15.3% 30.6% 
In author's study there were no cases among oligomenorrhea 
patients who had hyperthyroidism. In present study 15.3% 
oligomenorrheic patients were showing hyperthyroidism, 15.3% were 
having hypothyroidism. Total patients showing thyroid dysfunction in 
present study is 30.6% in author's study is 80%. 
Thyroid dysfunction in relation to oligomenorrhea. 
Table 18 : Hypothyroidism  in Oligomenorrheic  Patients. 
 Hypothyroid 
Present Study 50% 
Lakshmi Singh  et al 1990 36.3% 
  
 
 
 
The table  above  shows the  relationship  of  Hypothyroidism  to  
oligomenorrhea in the present study and author's study (Lakshmi Singh et 
al 1990). 
Author's study was conducted on infertile patients with menstrual 
aberrations. 
In author's study patients with oligomenorrhea and thyroid  
dysfunction showed 63.6%  of hyperthyroidism and 36.3% of 
hypothyroidism. 
In the present study patients with oligomenorrhea and thyroid 
dysfunction showed 50% of hyperthyroid cases and 50% of hypothyroid 
cases. In the present study hyperthyroidism was seen only in cases of 
oligomenorrhea. In author's study (Lakshmi singh et al  
1990)hyperthyroidism was seen in 64% of cases with oligomenorrhea. 
So in both the present study and author's study (Lakshmi Singh et 
al 1990) oligomenorrhea was the commonest menstrual aberration among 
hyperthyroid patients.. 
  
  
 
 
 
Table 19 :Oligomenorrhea in Hyperthyroidism 
Study Oligomenorrheic patients 
Author's Study 64% 
Present Study 100% 
 
Table :20 
Signs and symptoms of thyroid dysfunction 
 
Signs & symptoms No of cases hypothyroid Hyperthyroid 
Fatigue 18 6 - 
Cold intolerance 4 2 - 
Heat intolerance - - - 
obesity 8 4 - 
goiter 2 2 - 
Dry skin and hair loss 4 3 - 
In our study, most of  the  patients had  easy fatiguability  followed  
by weight gain,dry skin and  hair loss, cold  intolerance, goiter. None of 
the  patients  had  tachycardia, bradycardia, delayed  tendon  reflexes, eye  
signs,hypertension, heat  intolerance,palpitation. A  high  percentage  of  
women  presenting  with  fatigue,obesity,cold  intolerance, dry skin 
turned out to be  hypothyroid when investigated  biochemically. 
  
 
 
 
CONCLUSION 
 
o Our study concludes that thyroid dysfunction should be considered 
as an important etiological factor for menstrual abnormality.   
o Thus  biochemical evaluation of  T3, T4 and TSH estimations 
should be made  mandatory  in DUB cases to detect apparent and 
occult thyroid dysfunction. 
o Thyroid  function tests  should also  be done in  patients  presenting  
with  fatigue,obesity,lethargy  in addition  to  infertility,delayed  
puberty and recurrent  abortions. 
o These patients with thyroid dysfunction if given medical treatment  
avoids  necessity  of  hormonal treatment or surgical intervention. 
 
 
 
 
 
 
  
 
 
 
SUMMARY 
100 cases, clinically diagnosed as DUB selected from  department 
of obstetrics and  gynecology  , Coimbatore medical college hospital, 
Coimbatore , Tamil nadu  over a period of  12 months were studied. 
    Study was aimed to evaluate and detect thyroid dysfunction in 
patients with provisional diagnosis of DUB and positive cases i.e., 
patients showing thyroid dysfunction were referred to  physician for 
further management. 
1. In present study the patients belonged to various age groups 
ranging from below 20 years  to 45 years. Maximum number of 
cases belonged to 31-40 years- 36%. 
2. Parity of patients ranged from unmarried -0-5 maximum number of 
patients with DUB  belonged to unmarried group - 25%. 
3. Commonest bleeding pattern was menorrhagia (32%). 
4. Thyroid dysfunction was noted in 23% of cases (Subclinical 
hypothyroidism in 13%, Hypothyroidism in 7%, and  
hyperthyroidism  in 3 % of cases). 
  
 
 
 
5. Thyroid   dysfunction   was   commonest   in   cases   with 
polymenorrhea (37.5%), metropathia (33%), oligomenorrhea 
(31.5%) and  in menorrhagia(25%). 
6. Thyroid dysfunction was commonest in age group(31-40 years) 
7. Thyroid dysfunction was commonest in nulliparous women (33%). 
8. Predominant thyroid dysfunction was hypothyroidism total was 
20% among  that  subclinical hypothyroidism was in 13% of cases. 
9. 3% of cases who were hyperthyroid  were oligomenorrheic. 
10. Subclinical hypothyroidism was maximum among polymenorrheic 
patients (37.5%) and followed with menorrhagic  patients(18.75%). 
11. All 23% of cases who had thyroid dysfunction showed abnormal 
TSH levels 8% of  cases with thyroid dysfunction showed 
abnormal T3 level, 12% of cases  with thyroid dysfunction showed 
abnormal T4 levels. Thus TSH level has maximum sensitivity 
compared to T3 and T4 levels, in detecting thyroid gland 
dysfunction. 
12. Patients  having  symptoms  like  fatigue, increased weight gain, 
dry skin, cold intolerance  have  high incidence of  hypothyroidism. 
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ANNEXURE- I 
 
PROFORMA 
 
NAME :                                                                AGE: 
HOSPITAL NO:                                                 OCCUPATION: 
ADDRESS:           
SOCIO- ECONOMIC STATUS : 
 
CHIEF COMPLAINTS : 
 
HISTORY OF PRESENTING COMPLAINTS : 
A) Bleeding per Vagina : 
           Duration : 
           Interval : 
          Quantity : Scanty / Moderate /Excessive 
          H/o Dysmenorrhoea : Yes /No 
 
B) Other complaints  
THYROID RELATED COMPLAINTS 
HYPOTHYROIDISM(*) 
    Tiredness / mental lethargy / cold intolerance / weight gain / 
constipation / menstrual disturbances(menorrhagia). 
  
 
 
 
HYPERTHYROIDISM(*) 
    Heat intolerance / increased sweating / weight loss despite good 
appetite /palpitation /emotional lability /diarrhea / decreased fertility or 
miscarriages / amenorrhea. 
 
MENSTRUAL HISTORY : 
Metropathia hemorrhagica : yes /No 
     Hypomenorrhoea : Yes /No 
     Menorrhagia : Yes /No 
     Metrorrhagia : Yes /No 
     Oligomenorrhoea : Yes /No 
     Polymenorrhagia : Yes /No 
     Polymenorrhoea : Yes /No 
 
Age of attainment of menarche: 
Previous Menstrual cycles: 
Duration of Cycles : 
Amount of flow : 
Duration of flow : 
Associated dysmenorrhoea: 
Date of last menstrual period : 
  
 
 
 
OBSTETRIC HISTORY : 
Married Since :                 Para :                 Living :                Abortion :     
Last Delivery: 
Contraception :OCP / IUCD / BARRIER / NO 
Type of Deliveries:                                          Tubectomy :    Yes / No 
 
 PAST HISTORY : 
                    DM / HT 
TB / Bronchial asthma/ RHD/Blood transfusion / Any operations 
Drug intake ( thyroxine / antithyroid drugs ) or any other drugs. 
 
 FAMILY HISTORY : 
Thyroid disorders 
Any cancer 
 PERSONAL HISTORY : 
Diet :                                          Appetite:                                  Bowels: 
Micturation:                                                                                 Sleep: 
 
EXAMINATION OF PATIENT: 
General Condition:                                                  Nutritional Status: 
  
  
 
 
 
Anaemia  /  pedal edema   / clubbing  / lymphadenopathy . 
CVS : 
R S    : 
Pulse rate  
Blood Pressure 
 
PER ABDOMEN : 
Operative scar : Present / Absent 
Engorged vein : Present / Absent 
Ascites : Present / Absent 
Any enlargement of 
Liver / Spleen : Palpable / Non Palpable 
 
PER SPECULUM EXAMINATION: 
Vagina : 
Cervix : 
Bleeding : Present / Absent 
PER VAGINAL EXAMINATION: 
 
Cervix : Normal / Flush with vault 
  
  
 
 
 
Uterus :                    Anteverted / Retroverted 
                                 Normal size / Bulky/ smaller 
                                 Soft / Firm / Hard 
                                 Mobile / Fixed 
                                 Tender / Non Tender 
     Tenderness in fornix : Present / Absent 
      Uterocervical length : 
 
Per rectal Examination : 
THYROID EXAMINATION 
Neck examination   : gland enlarged / not 
  
HYPOTHYRIODISM 
Bradycardia /Cold extremities /dry skin & hair /periorbital puffiness 
/horse voice/delayed relaxation phase of ankle jerk/obesity/fatigue 
 
HYPERTHYROIDISM 
Tachycardia / warm and moist palms /eye signs / pretibial myxedema / 
tremor/heat intolerance/palpitation/weight loss/hypertension . 
  
  
 
 
 
INVESTIGATIONS : 
Hb %                                    RBS (mgs%): 
 
Urine  -Albumin:                      Sugar:                                    
Microscopy: 
BT :                                          CT: 
 
Thyroid Function Test 
 T3  
 T4 
TSH        
Impression: euthyroid  /  hypothyroid / hyperthyroid /subclinical 
hypothyroidism. 
  
IMAGING: 
Pelvic USG 
PAP SMEAR 
Histopathology of  endometrium. 
 
 
  
 
 
 
ANNEXURE – II 
VOLUNTEER'S CONSENT FORM 
 
This study has been explained to me and I understand: 
a)What the study involves 
b)That refusal to participate will not affect my treatment in any way. 
c)That I may withdraw at any time. 
 
I therefore agree to take part in this study. 
Signature of the subject ................................................................ 
 
Full Name : ......................................................................  
Date : ................................................................................ 
Full address :   
 
I HAVE BEEN PRESENT WHILE THE PROCEDURE HAS BEEN 
EXPLAINED TO THE SUBJECT AND I HAVE WITNESSED HIS / 
HER CONSENT TO TAKE  PART. 
 
Signature of the witness   
(The witness should be a person NOT connected with the study) 
Full Name :   
 
Date :  .......... 
 
Full address :       
  
 
 
 
KEY TO MASTER CHART 
 
Um  - unmarried 
LMP  – last menstrual period 
irre  – irregular period   
Hypo thy  – hypothyroid 
Sub.hypo  – subclinical hypothyroid 
Hyper   - hyperthyroidism 
P - present 
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1 69188 11/16/2012 VALLIYAMMAL 19 um 38 scanty 2 19 oligomenorrhoea 99 8.4 1.88 p       
2 69163 11/16/2012 PALANIAMMAL 30 5 28 excessive 5 4 menorrhagia 94 6.7 1.57         
3 69160 11/16/2012 GANOJEYAM 45 3 30 excessive 7 25 menorrhagia 61 2.1 110   p     
4 70008 11/20/2012 MYELATHAL 33 4 30 excessive 6 20 menorrhagia 92 7.1 1.22 p       
5 70811 11/23/2012 SIVABAGYAM 45 5 20 moderate 4 10 polymenorrhoea 88 5.8 9.58     p   
6 71665 11/27/2012 SURABHI 40 3 30 excessive 7 10 menorrhagia 158 10.3 1.33 p       
7 71633 11/27/2012 DHANABACKIYAM 25 2 20 excessive 8 10 polymenorrhagia 144 8.8 3.73 p       
8 69985 11/27/2012 SAVITHRI 40 3 30 excessive 7 14 menorrhagia 117 9.9 6.13     p   
9 72305 11/30/2012 JEEVARATHINAM 42 2 35 excessive 8 13 acyclical(MPH) 40 5.2 11.6   p     
10 73153 12/4/2012 MYELATHAL V 30 3 15 excessive 8 20 polymenorrhagia 114 10.9 2.8 p       
11 78239 12/28/2012 SELVI 45 1 15 excessive 6 3 polymennorhagia 92 6.2 2.54 p       
12 479 1/11/2013 JAGADEESHWARI 28 2 20 excessive 8 10 polymennorhagia 115 8 3.08 p       
13 70059 2/19/2013 PAPATHY 30 2 20 excessive 15 20 polymennorhagia 106 8.3 3.68 p       
14 740053 2/5/2013 MAHARAJALAKSHMI 40 5 20 excessive 8 15 polymennorhagia 160 10.1 2.52         
  
 
 
 
15 749323 2/8/2013 CHANDRA 40 4 30 excessive 8 20 menorrhagia 117 9.3 1.7 p       
16 749852 2/8/2013 VALMANI 45 3 20 excessive 9 8 polymenorrhagia 116 6.9 2.7 p       
17 757284 2/12/2013 SELVI 35 4 25 excessive 7 18 menorrhagia 70 7.5 13     p   
18 768952 2/15/2013 PADMAVATHY 30 4 24 excessive 6 1 menorrhagia 141 12.7 2.43 p       
19 14047 3/8/2013 THANGAMANI 21 1 30 excessive 10 15 menorrhagia 133 5.7 1.14 p       
20 14826 3/8/2013 SHANTHAMANI 35 5 90 excessive 7 60 acyclical(MPH) 88 9.4 1.24 p       
21 14859 3/8/2013 LAKSHMI 30 4 60 excessive 10 25 acyclical(MPH) 145 8.1 2.96 p       
22 14064 3/19/2013 RATHNA 35 3 25 excessive 10 5 menorrhagia 111 8.3 15.6     p   
23 16429 3/22/2013 VIJAYALAKSHMI 23 2 30 excessive 8 10 menorrhagia 100 8.3 4.39 p       
24 15730 3/22/2013 RAJESWARI 38 3 20 excessive 10 15 polymenorrhagia 88 7.6 12.5     p   
25 201041 3/19/2013 JEYAMANI 25 5 45 excessive 10 7 acyclical(MPH) 81 5.3 1.69 p       
26 207387 3/22/2013 MAHESWARI 14 um 60 excessive 10 90 acyclical(MPH) 100 7.5 2.1 p       
27 207431 3/22/2013 HASEENA BANU 18 um 30 excessive 9 15 menorrhagia 112 6.9 15.9     p   
28 221304 3/29/2013 VASANTHI 15 um 45 scanty 3 35 oligomenorrhoea 50 0.3 110   p     
29 221331 3/29/2013 MAHESHWARI 40 5 90 excessive 15 30 acyclical 113 9.4 1.14 p       
30 18804 4/2/2013 VIJAYALAKSHMI 38 3 15 excessive 6 6 polymenorrhagia 112 11 3.9 p       
31 23544 4/23/2013 VIJAYALAKSHMI 17 um 45 excessive 15 18 acyclical(MPH) 133 5.7 15.5     p   
32 242277 4/30/2013 SAROJA 16 um 30 excessive 8 20 menorrhagia 124 8 2.24 P       
33 25017 4/30/2013 SELVI 45 4 45 excessive 20 15 acyclical(MPH) 90 8.6 2.35 p       
34 229551 4/2/2013 KOKILA 15 um 30 excessive 8 20 menorrhagia 86 7.5 1.11 p       
35 201011 4/2/2013 KALAIVANI 18 um 90 scanty 2 20 oligomenorrhoea 176 9.1 0.83 p       
36 520954 4/2/2013 ANNAPOORANI 30 4 45 scanty 2 15 oligomenorrhoea 194 12 0.12       p 
  
 
 
 
37 233638 4/5/2013 MUTHURANI 15 um 30 heavy 15 20 menorrhagia 56 0.5 150   p     
38 233750 4/5/2013 SUGANTHI 42 3 20 excessive 6 18 polymenorrhagia 94 8 3.21 p       
39 27165 5/10/2013 THAI 41 2 45 scanty 2 5 oligomenorrhoea 158 8.3 1.49 p       
40 28013 5/14/2013 SHANTHI 35 2 20 moderate 5 12 polymenorrhoea 116 8.6 1.86 p       
41 30297 5/24/2013 MAHALAKSHMI 24 5 35 excessive 15 15 acyclical(MPH) 80 7.8 1.62 p       
42 28140 24-May NEELA 15 um 45 excessive 3 45 acyclical(MPH) 163 11.7 1.29 p       
43 31840 5/31/2013 SAROJA 45 3 20 excessive 9 8 polymenorrhagia 89 7.5 4.25 p       
44 286137 5/3/2013 SUMATHI 32 4 45 excessive 8 15 acyclical(MPH) 143 9.1 13.3     p   
45 280238 5/3/2013 RANI 30 2 30 excessive 8 10 menorrhagia 97 7.1 2.13 p       
46 287682 5/3/2013 VANI 25 2 30 excessive 8 15 menorrhagia 119 10 5.79     p   
47 293258 5/7/2013 KASTHURI THILAGA 24 2 30 scanty 1 20 oligomenorrhoea 294 12 0.12       p 
48 293293 5/7/2013 DHANALAKSHMI 30 3 20 excessive 12 20 polymenorrhagia 136 11.1 3.3 p       
49 33687 6/5/2013 RUKMANI 36 3 18 excessive 4 10 polymenorrhagia 134 9 2.51 p       
50 33688 6/18/2013 SULOCHANA 32 2 45 scanty 1 30 oligomenorrhoea 188 12.1 3.24 p       
51 37598 6/25/2013 SUBBULAKSHMI 29 3 35 scanty 2 13 oligomenorrhoea 131 9 1.86 p       
52 38282 6/28/2013 MARIAMMAL 15 um 30 excessive 8 4 menorrhagia 123 7.6 1.96 p       
53 34547 6/11/2013 VIJAYALAKSHMI 35 2 30 excessive 10 15 menorrhagia 90 9 7.5     p   
54 34078 6/11/2013 LATHA 32 1 45 scanty 2 35 oligomenorrhoea 111 7.1 1.99 p       
55 34104 6/11/2013 VASANTHA 35 2 20 excessive 8 15 polymenorrhagia 124 9 3.3 p       
56 35395 6/15/2013 NEELAVATHY 45 4 30 excessive 10 12 menorrhagia 133 10 1.29 p       
57 37798 6/26/2013 LATHA 16 um 25 excessive 8 90 acyclical(MPH) 109 8 2.87 p       
58 36314 6/26/2013 KALIYAMMAL 15 um 90 excessive 10 90 acyclical(MPH) 9 0.7 150   p     
  
 
 
 
59 38281 6/28/2013 PALANIAMMAL 35 3 60 excessive 10 15 acyclical(MPH) 20 0.8 100         
60 39087 7/1/2013 LAKSHMI 19 um 30 scanty 1 20 hypomenorrhoea 149 11.3 0.4 p       
61 40580 7/5/2013 MANJULA 40 2 20 excessive 5 5 polymenorrhagia 116 10.3 3.3 p       
62 41333 7/5/2013 MARIAMMAL 25 um 35 scanty 1 30 oligomenorrhoea 122 8.1 1.27 p       
63 41327 7/8/2013 AMSAVENI 30 2 30 excessive 8 25 menorrhagia 144 8.9 1.98 p       
64 498133 7/23/2013 SELVI 35 3 irre scanty 2 10 metrorrhagia 111 7 2.31 p       
65 45368 7/26/2013 DHANALAKSHMI 30 2 30 scanty 1 15 hypomenorrhoea 120 9.2 1.74 p       
66 35646 7/1/2013 LAKSHMI 40 2 20 excessive 8 10 polymenorrhoea 139 9.3 6.05     p   
67 38466 7/1/2013 REVATHI 36 3 30 excessive 8 15 menorrhagia 141 9 1.91 p       
68 38282 7/2/2013 MARIYAMMAL 19 um 90 scanty 5 90 oligomenorrhoea 95 6 11.6     p   
69 38465 7/3/2013 SELVI 15 um 20 excessive 8 5 polymenorrhoea 118 28 2.06 p       
70 38654 7/6/2013 SANTHA 40 4 irre scanty 3 8 metrorrhagia 138 9.3 3.22 p       
71 38685 7/8/2013 SUGANTHI 16 um 20 moderate 5 18 polymenorrhoea 126 10.9 1.76 p       
72 48328 8/9/2013 RENUGADEVI 30 1 30 scanty 1 15 hypomenorrhoea 130 10.2 1.62 p       
73 534258 8/2/2013 KALYANI 23 0 90 moderate 4 4 oligomenorrhoea 16 0.6 150   p     
74 534385 8/2/2013 SHANMUGAPRIYA 35 2 40 moderate 2 15 oligomenorrhoea 120 7.5 1.64 p       
75 515942 8/2/2013 JEYAKKODI 35 1 33 scanty 1 19 hypomenorrhoea 114 8.2 4.7 p       
76 544298 8/6/2013 SOWJATH 26 0 40 scanty 2 40 oligomenorrhoea 135 6.4 1.69 p       
77 545826 8/6/2013 USHA 21 0 30 scanty 1 15 hypomenorrhoea 118 7.4 1.66 p       
78 544547 8/6/2013 CHITRA 36 1 20 excessive 8 7 polymenorrhagia 121 10.4 1.65 p       
79 546008 8/6/2013 MATHU 35 3 45 scanty 1 15 oligomenorrhoea 114 8 4.5 p       
80 577825 8/23/2013 MARAGATHAM 17 um 30 excessive 5 15 menorrhagia 182 9.6 5.28 p       
  
 
 
 
81 585725 8/20/2013 MEENA 35 1 40 scanty 2 8 oligomenorrhoea 225 13 0.03       p 
82 53056 9/3/2013 SAMEENA 38 2 30 excessive 7 10 menorrhagia 127 6.8 3.58 p       
83 52516 9/6/2013 RUKUMANI 32 3 60 excessive 6 1 acyclical(MPH) 153 7.9 4.29 p       
84 52112 9/6/2013 JEYAMANI 28 0 50 scanty 1 25 oligomenorrhoea 160 7.6 4.22 p       
85 56772 9/24/2013 DHANALAKSHMI 35 0 20 moderate 5 15 polymenorrhoea 149 4.6 26.2     p   
86 567227 9/24/2013 THILSATH 20 um 30 excessive 8 10 menorrhagia 175 8 4.57 p       
87 608361 9/3/2013 POOMANI 23 um 30 excessive 8 14 menorrhagia 92 7.25 1.22 p       
88 600929 9/3/2013 CHITARA 28 0 28 excessive 5 10 menorrhagia 114 6.9 2.47 p       
89 614741 9/6/2013 DEVI 45 3 20 excessive 10 15 polymenorrhagia 144 8.8 2.4 p       
90 622264 9/10/2013 RABI 38 2 50 scanty 1 35 oligomenorrhoea 117 8.3 2.8 p       
91 637266 9/17/2013 GEETHA 40 3 15 excessive 5 20 polymenorrhagia 106 9 1.22 p       
92 60820 10/8/2013 LAKSHMI 32 1 30 excessive 6 20 menorrhagia 141 10.2 2.43 p       
93 60802 10/8/2013 FATHIMA 40 3 55 scanty 2 40 oligomenorrhoea 158 7.1 1.33 p       
94 60849 10/8/2013 PARVATHI 29 1 30 excessive 8 10 menorrhagia 117 7.2 1.57 p       
95 61578 10/22/2013 SANGEETHA 17 um 30 excessive 7 15 menorrhagia 88 7.1 2.47 p       
96 705002 10/18/2013 SHARMILA 30 2 28 excessive 7 10 menorrhagia 160 10.1 2.54 p       
97 705055 10/18/2013 DEIVA 15 um 26 excessive 5 15 menorrhagia 106 7.6 3.73 p       
98 719129 10/25/2013 AABISHA 20 um irre scanty 1 5 metrorrhagia 144 6.9 1.33 p       
99 713186 10/22/2013 NANDHINI 18 um 20 moderate 5 10 polymenorrhoea 166 7.6 4.1 p       
100 712056 10/22/2013 JEYANTHI 30 2 15 moderate 2 10 polymenorrhoea 105 8.3 2.3 p       
 
